Patient

P2B-079

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Sarcoma Oncology Center (Santa Monica, CA) (Dr. Reyes)

consented 2013-02-22

Sarcoma Oncology Center (Santa Monica, CA)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

mild assessed 2013-06-03

Grade 1 nausea with onset in cycle 5 (2013-06-03); assessed as not related to study drug (unlikely); resolved 2013-06-07.

mild assessed 2013-05-25

Grade 1 anaemia with onset in cycle 4 (2013-05-25); assessed as related to study drug (probable); resolved 2013-06-16.

mild assessed 2013-05-11

Grade 1 vomiting with onset in cycle 4 (2013-05-11); assessed as not related to study drug (not related); resolved 2013-05-14.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users